Big biotech deals

CP Reports
CP Insight
Current Agreements
CP Knowledge Centre
CP Consulting

Derived from Current Agreements, our editors have selected notable big biotech deals from the life sciences in recent weeks – our Featured deals. Subscribe to our weekly newsletter to be updated on new featured deals and much more.

For comprehensive access to all life science deals as they are announced:

Deal Monitor - part of Current Partnering Insight, Deal Monitor allows you to track recent deals by industry sector, therapy area, technology type and stage of development - access now

Current Agreements - search over 40,000 deals to find benchmarks, monitor target company deal structures, identify companies active in your area(s) of interest, and much more - access now

Featured big biotech deals

All big biotech deals: Deal Monitor | Current Agreements

When de-risking, relationships matter: How using key strategies can get you to your next innovative partnership

bridiedurcan : August 10, 2015 3:58 PM : Big biotech, Big pharma, Biotech, Deals, Partnering, Pharma

An interview with Richard Brudnick, Senior VP, Corporate Development, Biogen

De-risking has evolved from literature searches to the cultivation of many wide-ranging relationships throughout the life sciences strata, according to Richard Brudnick, Senior VP, Corporate Development at Biogen. In a recent interview, Brudnick outlined key strategies to accessing innovation and “de-risking” risk through collaboration. more »

Leave a response »

Morphosys acquires Lanthio Pharma

Raveena Bhambra : May 7, 2015 4:55 PM : Big biotech, Deals

MorphoSys has acquired all outstanding shares of the Dutch biopharmaceutical company Lanthio Pharma B.V. more »

Leave a response »

Alexion to buy Synageva Biopharma

Raveena Bhambra : May 5, 2015 12:04 PM : Big biotech, Deals

Alexion Pharmaceuticals have entered into a definitive agreement pursuant to which Alexion will acquire Synageva for consideration of $115 in cash and 0.6581 Alexion shares, for each share of Synageva, implying a total per share value of $230 based on the nine day volume-weighted average closing price of Alexion stock through May 5, 2015. more »

Leave a response »

Celgene acquires Quanticel Pharmaceuticals

Steve Poile : April 28, 2015 6:37 AM : Big biotech, Big pharma, M&A

Celgene and Quanticel Pharmaceuticals announced a definitive share purchase agreement under which Celgene will acquire Quanticel more »

Leave a response »

MedImmune and Immunocore partner for melanoma combinations

Steve Poile : April 20, 2015 10:25 AM : Big biotech, Biotech, Partnering

Immunocore will conduct a Phase Ib/II clinical trial combining checkpoint inhibitors MEDI4736 (anti-PD-L1) and/or tremelimumab (anti-CTLA-4) with IMCgp100 more »

Leave a response »

Mesoblast banks $45mn financing from Celgene

Steve Poile : April 14, 2015 11:40 AM : Big biotech, Financing

Mesoblast has entered into an Agreement with Celgene more »

Leave a response »

Morphosys regains MOR202 rights from Celgene

Steve Poile : March 27, 2015 10:31 AM : Big biotech, Big pharma, Biotech, Partnering

MorphoSys has regained rights to MOR202 from Celgene more »

Leave a response »

Celgene and Open Monoclonal Tech in OmniAb alliance

Steve Poile : March 12, 2015 4:06 PM : Big biotech, Big pharma, Partnering

Open Monoclonal Technology announced license that provides Celgene with unlimited access to OMT’s proprietary OmniRat, OmniMouse and OmniFlic platforms for generation of human antibody therapeutics more »

Leave a response »

MedImmune partners with Joslin for diabetes

Steve Poile : March 12, 2015 4:00 PM : Big biotech, Big pharma, Partnering, Pharma

MedImmune and Joslin Diabetes Center announced a three-year research collaboration to develop new medicines for the treatment of diabetes, obesity, and related metabolic disorders more »

Leave a response »

Alexion and Blueprint partner on activated kinase target

Steve Poile : March 4, 2015 12:29 PM : Big biotech, Partnering

Blueprint Medicines announced a strategic collaboration with Alexion to discover, develop and commercialize novel drug candidates more »

Leave a response »
« Page 1, 2, 3 ... 24, »

Derived from Current Agreements, more featured partnering deals by category:

Big pharma

Pfizer creates breaking news with Allergan purchase

November 23, 2015

When de-risking, relationships matter: How using key strategies can get you to your next innovative partnership

August 10, 2015

Boehringer Ingelheim acquires Pharmaxis’ anti-inflammatory candidate

May 18, 2015

View more featured deals | all deals at Deal Monitor

Pharma

Pfizer creates breaking news with Allergan purchase

November 23, 2015

When de-risking, relationships matter: How using key strategies can get you to your next innovative partnership

August 10, 2015

Pfizer in asset purchase and option to acquire AM-Pharma

May 12, 2015

View more featured deals | all deals at Deal Monitor

Biotech

When de-risking, relationships matter: How using key strategies can get you to your next innovative partnership

August 10, 2015

Veracyte banks $40 million private placement

April 28, 2015

MedImmune and Immunocore partner for melanoma combinations

April 20, 2015

View more featured deals | all deals at Deal Monitor

Diagnostics

Ventana and Astellas in automated tissue diagnostics pact

April 15, 2015

Roche acquires Signature Diagnostics for access to translational oncology and genomics

February 12, 2015

Personalis gains $33 million series C

January 14, 2015

View more featured deals | all deals at Deal Monitor

Medical device

Abbott to distribute Sekiui’s coagulation testing solutions

April 15, 2015

Mallinckrodt acquires Ikaria for $2.3bn

March 5, 2015

Intuitive Surgical wins $430m surgical robotic systems contract

March 5, 2015

View more featured deals | all deals at Deal Monitor

Drug delivery

Janssen and Ichor Medical enter hep B vaccine delivery alliance

April 14, 2015

Sanofi Pasteur and VBI Vaccines in formulation pact

April 9, 2015

Sanofi and Vect-Horus collaborate to transport therapeutic antibodies into brain

January 20, 2015

View more featured deals | all deals at Deal Monitor

Print Friendly, PDF & Email